P.M. Fisher

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni et al. · Annals of Oncology · 2020 · 265 citations · Full text

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

Martin F. Muers, Richard Stephens, P.M. Fisher et al. · The Lancet · 2008 · 257 citations · Full text

Malignant Pleural Mesothelioma, Oncology, Cancer Management +5

A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni‐Fontecedro, Varvara Polydoropoulou et al. · Annals of Oncology · 2019 · 54 citations · Full text

Oncology, Phase Iii Trial, Clinical Trials +7

Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716

Sarah Danson, Joe Conner, John Edwards et al. · Lung Cancer · 2020 · 53 citations

Phase I/iia Trial, Cancer-associated Virus, Intrapleural Administration +7

Group therapy for adult women survivors of child sexual abuse: Differentiation of completers versus dropouts.

P.M. Fisher, Philip H. Winne, Robert G. Ley · Psychotherapy · 1993 · 32 citations

Family Medicine, Sexual Abuse, Gender Studies +9